[go: up one dir, main page]

ZA200303910B - Biphenylcarboxamides useful as lipid lowering agents. - Google Patents

Biphenylcarboxamides useful as lipid lowering agents. Download PDF

Info

Publication number
ZA200303910B
ZA200303910B ZA200303910A ZA200303910A ZA200303910B ZA 200303910 B ZA200303910 B ZA 200303910B ZA 200303910 A ZA200303910 A ZA 200303910A ZA 200303910 A ZA200303910 A ZA 200303910A ZA 200303910 B ZA200303910 B ZA 200303910B
Authority
ZA
South Africa
Prior art keywords
formula
hydrogen
compound
halo
amino
Prior art date
Application number
ZA200303910A
Other languages
English (en)
Inventor
Lieven Meerpoel
Leo Jacobus Josef Backx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA200303910B publication Critical patent/ZA200303910B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/80—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
ZA200303910A 2000-11-21 2003-05-20 Biphenylcarboxamides useful as lipid lowering agents. ZA200303910B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00204150 2000-11-21

Publications (1)

Publication Number Publication Date
ZA200303910B true ZA200303910B (en) 2004-09-01

Family

ID=8172315

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200303910A ZA200303910B (en) 2000-11-21 2003-05-20 Biphenylcarboxamides useful as lipid lowering agents.

Country Status (31)

Country Link
US (5) US7135586B2 (fr)
EP (1) EP1339685B1 (fr)
JP (1) JP4190283B2 (fr)
KR (1) KR20030051718A (fr)
CN (1) CN1289481C (fr)
AR (1) AR035072A1 (fr)
AT (1) ATE344243T1 (fr)
AU (2) AU2002219115B2 (fr)
BG (1) BG107805A (fr)
CA (1) CA2427660C (fr)
CZ (1) CZ20031638A3 (fr)
DE (1) DE60124296T2 (fr)
DK (1) DK1339685T3 (fr)
EA (1) EA006101B1 (fr)
EE (1) EE200300234A (fr)
ES (1) ES2275759T3 (fr)
GC (1) GC0000312A (fr)
HU (1) HUP0400926A3 (fr)
IL (2) IL155945A0 (fr)
JO (1) JO2409B1 (fr)
MX (1) MXPA03004465A (fr)
MY (1) MY134167A (fr)
NO (1) NO20032272L (fr)
NZ (1) NZ526495A (fr)
PA (1) PA8532001A1 (fr)
PL (1) PL205290B1 (fr)
PT (1) PT1339685E (fr)
SI (1) SI1339685T1 (fr)
SK (1) SK7522003A3 (fr)
WO (1) WO2002042271A2 (fr)
ZA (1) ZA200303910B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
WO2002098839A1 (fr) * 2001-06-01 2002-12-12 Tanabe Seiyaku Co., Ltd. Biphenylcarboxamides et procede de preparation de ceux-ci
IL161134A0 (en) 2002-02-28 2004-08-31 Japan Tobacco Inc Ester compound and medical use thereof
EP1485348B1 (fr) 2002-03-13 2008-06-11 Janssen Pharmaceutica N.V. Derives carbonylamino utilises en tant que nouveaux inhibiteurs d'histone deacetylase
US7501417B2 (en) 2002-03-13 2009-03-10 Janssen Pharmaceutica, N.V. Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
UA79300C2 (en) * 2002-08-12 2007-06-11 Janssen Pharmaceutica Nv N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
AU2003286347A1 (en) * 2002-12-20 2004-07-14 Pfizer Products Inc. Microsomal triglyceride transfer protein inhibitors
US7223788B2 (en) 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP1669345A4 (fr) 2003-08-29 2008-02-20 Japan Tobacco Inc Derive d'ester et utilisation medicale de celui-ci
FR2871463B1 (fr) * 2004-06-11 2006-09-22 Merck Sante Soc Par Actions Si Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
PL1781639T3 (pl) 2004-07-28 2012-07-31 Janssen Pharmaceutica Nv Podstawione pochodne indolilo-alkiloaminowe jako nowe inhibitory deacetylazy histonowej
US8101774B2 (en) 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
WO2007053436A1 (fr) 2005-10-31 2007-05-10 Janssen Pharmaceutica N.V. Piperazines et piperidines substituees en tant que modulateurs du recepteur du neuropeptide y2
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
JP5247470B2 (ja) 2006-01-19 2013-07-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼのインヒビターとしてのピリジン及びピリミジン誘導体
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
WO2009006185A1 (fr) * 2007-07-03 2009-01-08 Janssen Pharmaceutica, N.V. Dérivés pipérazinylés utiles comme modulateurs du récepteur de neuropeptide y2
US10491357B2 (en) * 2010-07-12 2019-11-26 Entropic Communications Llc Method and apparatus for using dynamic subchannels in a communications network

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) * 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
US3929801A (en) * 1973-11-20 1975-12-30 Janssen Pharmaceutica Nv 2-Benzimidazolinones
US3929601A (en) * 1974-03-26 1975-12-30 Us Energy Synthesis of pentafluorides
DE2852203C3 (de) * 1978-12-02 1982-03-11 Ibm Deutschland Gmbh, 7000 Stuttgart Lichtleiteinrichtung für eine mit Auflicht betriebene Abbildungsvorrichtung
US4231576A (en) * 1979-02-21 1980-11-04 Perkins Sonnie J Golf club head alignment apparatus
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444764A (en) * 1979-08-06 1984-04-24 The Dow Chemical Company Phosphorus esters of alkylcycloalkyl-5-pyrimidinols and control of corn rootworm and western spotted cucumber beetle with them
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
DE3124366A1 (de) * 1981-06-20 1982-12-30 Hoechst Ag, 6000 Frankfurt N-oxacyclyl-alkylpiperidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und deren verwendung
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
DE3410498A1 (de) * 1984-03-22 1985-10-03 Hoechst Ag, 6230 Frankfurt N-bicycloheptyl- und n-bicycloheptenyl-imidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US4847271A (en) * 1986-01-27 1989-07-11 Merck & Co., Inc. Antihypercholesterolemic β-lactones
US5041432A (en) * 1987-01-30 1991-08-20 E. I. Du Pont De Nemours And Company Steroid derivatives useful as hypocholesterolemics
GB8716059D0 (en) * 1987-07-08 1987-08-12 Anderson Strathclyde Plc Mining machine
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
US5064858A (en) * 1988-08-17 1991-11-12 Spectrum Pharmaceutical Corporation Protected complex of procaine for the treatment of symptoms from narcotics addiction, tinnitus and Alzheimer's disease
US5232833A (en) * 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
US5064856A (en) * 1989-07-31 1991-11-12 Merck & Co., Inc. Novel hmg-coa synthase inhibitors
US5120729A (en) * 1990-06-20 1992-06-09 Merck & Co., Inc. Beta-lactams as antihypercholesterolemics
US5177080A (en) * 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
DE4040203A1 (de) 1990-12-15 1992-06-17 Roehm Gmbh Eingetruebte kunststoffelemente
WO1992018113A1 (fr) * 1991-04-18 1992-10-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Identification d'une nouvelle espece d'ehrlichia a partir d'un patient souffrant d'ehrlichiose
DE4140540A1 (de) * 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
EP0618803A4 (fr) * 1991-12-19 1995-03-22 Southwest Found Biomed Res Polypeptide inhibant la proteine de transfert aux esters de cholesteryl, anticorps contre le polypeptide synthetique et traitements prophylactiques et therapeutiques anti-atherosclerose.
SI9300097B (en) 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
HU218419B (hu) 1992-03-06 2000-08-28 E.R. Squibb And Sons, Inc. Mikroszomális triglicerid transzfer protein (MTP) nagy molekulatömegű alegységének rekombináns úton történő előállítására és a protein és inhibitorainak kimutatására szolgáló eljárások
US5595872A (en) * 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
SG82630A1 (en) 1992-04-20 2001-08-21 Takeda Chemical Industries Ltd 4,1-benzoxazepin derivatives and their use
US5279454A (en) 1992-04-24 1994-01-18 Eastman Kodak Company Straight through lateral constraint
US5327875A (en) * 1993-02-19 1994-07-12 Hall S Franklin Vapor enhanced carburetion system
DE4319038A1 (de) * 1993-06-08 1994-12-15 Bayer Ag Verwendung von teilweise bekannten substituierten Chromanen als Arzneimittel, neue Wirkstoffe und Verfahren zu ihrer Herstellung
US5780248A (en) * 1993-07-15 1998-07-14 Ortho Diagnostic Systems, Inc. Foil sealed cassette for agglutination reactions and liner therefor
FI93396C (fi) 1993-08-17 1995-03-27 Petetronic Tmi P Kinnunen Optinen menetelmä nesteen pinnankorkeuden mittaamiseksi
CA2168021C (fr) 1993-08-19 2007-07-03 Guy Rosalia Eugene Van Lommen Derives du dihydrobenzopyrane, vasoconstricteurs
US5739135A (en) 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
AU678503B2 (en) 1993-09-24 1997-05-29 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds and their use as squalene synthetase inhibitors
US5492916A (en) * 1993-12-23 1996-02-20 Merck & Co., Inc. Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
CZ286403B6 (en) * 1993-12-07 2000-04-12 S & R Maschb Gmbh Apparatus for baking pies
JPH086412A (ja) * 1994-06-20 1996-01-12 Canon Inc 加熱装置および画像形成装置
AU3577995A (en) 1994-10-04 1996-04-26 Fujisawa Pharmaceutical Co., Ltd. Urea derivatives and their use as acat-inhibitors
US5510379A (en) * 1994-12-19 1996-04-23 Warner-Lambert Company Sulfonate ACAT inhibitors
US5536859A (en) 1995-02-27 1996-07-16 Amoco Corporation Alpha-olefin catalyst and process
GB9504066D0 (en) 1995-03-01 1995-04-19 Pharmacia Spa Phosphate derivatives of ureas and thioureas
US5541199A (en) * 1995-06-02 1996-07-30 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5919795A (en) * 1995-06-07 1999-07-06 Pfizer Inc. Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide derivatives, their preparation and their use as inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (Apo B) secretion
EP0832069B1 (fr) 1995-06-07 2003-03-05 Pfizer Inc. DERIVES DE BIPHENYL-2-ACIDE CARBOXYLIQUE-TETRAHYDRO-ISOQUINOLEINE-6-YL AMIDES, PREPARATION DE CES AMIDES ET UTILISATION EN TANT QU'INHIBITEURS DE LA PROTEINE DE TRANSFERT DE TRIGLYCERIDE MICROSOMAL ET/OU DE LA SECRETION D'APOLIPOPROTEINES B (Apo B)
US5696196A (en) * 1995-09-15 1997-12-09 Egyptian Lacquer Mfg. Co. EMI/RFI-shielding coating
US5827875A (en) * 1996-05-10 1998-10-27 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
JP2000517497A (ja) 1996-09-03 2000-12-26 シーメンス アクチエンゲゼルシヤフト 任意の数のデータを有するデジタルデータ流の暗号処理装置および処理方法
FR2756027B1 (fr) 1996-11-15 1999-01-15 Dimos Crochet de securite
BR9714364A (pt) * 1996-11-27 2000-03-21 Pfizer Amidas inibidoras da secreção de apo b/mtp
DE19649751C2 (de) 1996-11-30 1999-12-30 Cts Fahrzeug Dachsysteme Gmbh Dachaufbau für Fahrzeuge, insbesondere Personenkraftwagen
US5876070A (en) 1996-12-11 1999-03-02 Kennecott Holdings Corporation Pipe flange connection for pressure retaining, abrasive/corrosive service
GB9626045D0 (en) 1996-12-14 1997-01-29 Rover Group A vehicle roll stabilising system
US5760246A (en) * 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
WO1998027979A1 (fr) 1996-12-20 1998-07-02 Bristol-Myers Squibb Company Inhibiteurs heterocycliques de la proteine de transfert des triglycerides microsomiques et methode associee
US5966677A (en) 1997-02-28 1999-10-12 Fiekowsky; Peter J. High accuracy particle dimension measurement system
GB9705206D0 (en) 1997-03-13 1997-04-30 Automotive Prod Italia Drum brakes
US5968950A (en) * 1997-06-23 1999-10-19 Pfizer Inc Apo B-secretion/MTP inhibitor hydrochloride salt
US5988950A (en) * 1997-11-18 1999-11-23 Atlantic Richfield Company Method and system for preventing upward migration of contaminants in soil
GB9725782D0 (en) 1997-12-05 1998-02-04 Pfizer Ltd Therapeutic agents
US6133277A (en) 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
US5989950A (en) * 1998-01-26 1999-11-23 Texas Instruments - Acer Incorporated Reduced mask CMOS salicided process
US6173351B1 (en) 1998-06-15 2001-01-09 Sun Microsystems, Inc. Multi-processor system bridge
US6133217A (en) 1998-08-28 2000-10-17 Huntsman Petrochemical Corporation Solubilization of low 2-phenyl alkylbenzene sulfonates
US5985577A (en) * 1998-10-14 1999-11-16 The Trustees Of Columbia University In The City Of New York Protein conjugates containing multimers of green fluorescent protein
GB9826412D0 (en) * 1998-12-03 1999-01-27 Glaxo Group Ltd Chemical compounds
WO2000032532A1 (fr) 1998-12-03 2000-06-08 Lucio Alvaro Procede de traitement thermique de materiaux inorganiques et organiques dans une serie de petites cuves et appareil pour le mettre en oeuvre
EP1187831B1 (fr) 1999-06-02 2004-10-13 Janssen Pharmaceutica N.V. Derives substitues de pyrrolidinyle, de piperidinyle ou d'homopiperidinyle (benzodioxane, benzofurane ou benzopyrane)
WO2000075136A1 (fr) 1999-06-02 2000-12-14 Janssen Pharmaceutica N.V. Derives aminoalkyle substitues (benzodioxane, benzofurane ou benzopyrane)
WO2001077077A1 (fr) 2000-04-10 2001-10-18 Novartis Ag Derives d'(hetero)aryl-carboxamide en tant qu'inhibiteurs de la proteine microsomale de transfert des triglycerides (mtp) et de la secretion d'apolipoproteine b (apo b)
GB0013346D0 (en) * 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
JO2390B1 (en) 2001-04-06 2007-06-17 شركة جانسين فارماسوتيكا ان. في Diphenylcarboxamides act as lipid-lowering agents
CA2442141A1 (fr) 2001-04-09 2002-10-17 Eli Lilly And Company Composes et compositions pharmaceutiques destines a inhiber la proteine mrp1
GB0423422D0 (en) * 2004-10-21 2004-11-24 Bard Inc C R Medical device for fluid flow, and method of forming such device

Also Published As

Publication number Publication date
DK1339685T3 (da) 2007-03-12
SI1339685T1 (sl) 2007-04-30
US20080275087A1 (en) 2008-11-06
KR20030051718A (ko) 2003-06-25
CA2427660A1 (fr) 2002-05-30
PL205290B1 (pl) 2010-03-31
EP1339685A2 (fr) 2003-09-03
US20040102490A1 (en) 2004-05-27
EP1339685B1 (fr) 2006-11-02
ATE344243T1 (de) 2006-11-15
BG107805A (bg) 2004-01-30
EA200300597A1 (ru) 2003-10-30
US7538124B2 (en) 2009-05-26
US7304167B2 (en) 2007-12-04
IL155945A (en) 2009-06-15
NO20032272D0 (no) 2003-05-20
US20080009522A1 (en) 2008-01-10
EA006101B1 (ru) 2005-08-25
MY134167A (en) 2007-11-30
MXPA03004465A (es) 2003-08-19
HUP0400926A3 (en) 2008-03-28
GC0000312A (en) 2006-11-01
US7244848B2 (en) 2007-07-17
NO20032272L (no) 2003-05-20
US7405307B2 (en) 2008-07-29
WO2002042271A3 (fr) 2002-11-21
DE60124296T2 (de) 2007-05-31
HK1073310A1 (en) 2005-09-30
CN1289481C (zh) 2006-12-13
CZ20031638A3 (cs) 2004-02-18
AR035072A1 (es) 2004-04-14
JP4190283B2 (ja) 2008-12-03
WO2002042271A2 (fr) 2002-05-30
CA2427660C (fr) 2010-01-19
US7135586B2 (en) 2006-11-14
DE60124296D1 (de) 2006-12-14
US20060128973A1 (en) 2006-06-15
AU1911502A (en) 2002-06-03
CN1568312A (zh) 2005-01-19
HUP0400926A2 (hu) 2004-07-28
PT1339685E (pt) 2007-02-28
AU2002219115B2 (en) 2007-01-04
PA8532001A1 (es) 2002-10-28
NZ526495A (en) 2004-06-25
JP2004521870A (ja) 2004-07-22
SK7522003A3 (en) 2004-04-06
EE200300234A (et) 2003-08-15
US20060128972A1 (en) 2006-06-15
PL361633A1 (en) 2004-10-04
JO2409B1 (en) 2007-06-17
IL155945A0 (en) 2003-12-23
ES2275759T3 (es) 2007-06-16

Similar Documents

Publication Publication Date Title
ZA200303910B (en) Biphenylcarboxamides useful as lipid lowering agents.
ZA200301755B (en) Polyarylcarboxamides useful as lipid lowering agents.
Feldman et al. Design, synthesis, and pharmacological evaluation of ultrashort-to long-acting opioid analgesics
ZA200607542B (en) MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
AU2004247319A1 (en) Pyridinyl carbamates as hormone-sensitive lipase inhibitors
WO2000039077A3 (fr) Nouveaux ligands de recepteurs thyroidiens et procede ii
CA2336853A1 (fr) Derives d'acide phenoxyacetique et compositions medicinales contenant lesdits derives
PL190017B1 (pl) Zastosowanie analogów sibutraminy do wytwarzania leku
DE69013511T4 (de) Aminosäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE60217089T2 (de) Lipidsenkende biphenylcarbonsäureamide
PT97510A (pt) Processo de preparacao de novos derivados da 2-metoxifenilpiperazina
AU2002219115A1 (en) Biphenylcarboxamides useful as lipid lowering agents
EP1749539A2 (fr) Compositions pour la prévention ou le traitement de la stéatose hépatique
AU2002253171A1 (en) Lipid lowering biphenylcarboxamides
US4529730A (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
DE60103034T2 (de) Neue phenylheteroalkylamin-derivate
JP2004501888A (ja) ホスホジエステラーゼｉｖ阻害活性を有する薬剤の調製に有用な化合物
JPH03169841A (ja) アミノプロパノール誘導体およびそれを含有する薬剤組成物、ならびにそれらの製造方法
JPH05504578A (ja) 薬学組成物
EP2076487A1 (fr) Derives acide tetrahydro-naphtalene-1-carboxylique inhibant le mtp
JPWO1993005778A1 (ja) 血中脂質代謝改善剤
JPS6028831B2 (ja) 新規アミノアルコキシベンゾフラン類及びその製法
EP0647446A1 (fr) Nouvelle utilisation medicale d'un derive de dihydropyridine
EP1060162A1 (fr) Urethanes derives d'azacycloalcanes, leurs analogues thio et dithio, leur production et leur utilisation comme inhibiteurs de la 2,3-epoxysqualene-lanosterol-cyclase
WO1996031500A1 (fr) Composes heterocycliques nouveaux